The efficacy of a multimodal analgesia protocol in preventing heterotopic ossification after acetabular fractures surgery
- 196 Downloads
Background Heterotopic ossification (HO) after joint surgery is always a disturbing problem for patients and surgeons. Prophylaxis is the most effective therapy. Objective To assess the efficacy and safety of a multimodal analgesia protocol that included parecoxib and celecoxib in preventing HO after acetabular fracture surgery. Setting Selecting patients from trauma registry of our hospital. Method We identified 259 patients who had acetabular fracture surgery between January 2008 and December 2014. Hundredsixty-three patients received parecoxib and celecoxib (Group A) and 96 patients received no prophylaxis (Group B). The presence of HO was assessed according to the classification of Brooker et al. at the 12 month postoperative visit. Main outcome measure The differences in HO incidence and severity between the two groups. Results 49 patients (30.0%) developed HO in the Group A and 44(45.8%) in Group B. The difference in total HO incidence between the two groups was significant (P = 0.011 < 0.05, χ2 = 6.530, OR 0.508, 95% CI (0.301–0.857). Severe HO (Brooker grade III or IV) developed in 15 patients (9.2%) in Group A and 17 patients (17.7%) in Group B. Brooker grade I + II was 34(20.9%) and 27(28.1%) in each group. The difference in the severity of HO between the two Groups was significant (P = 0.008 < 0.05). Conclusion A short-term administration of parecoxib and celecoxib aids in the prevention of HO after acetabular fractures surgery.
KeywordsAcetabular fracture COX-2 Heterotopic ossification Multimodal analgesia
We are grateful to the staff of our medical record information section for providing the patients data.
This study was supported by the Grants from the Provincial Science Foundation of Hunan (No. 2015SK20474), Natural Science Foundation of Hunan Province (CN) (No. 2017JJ3477) and Xiangya Clinical Big Data Project (xyyydsj9).
Conflicts of interest
The authors declare that they have no conflict of interest.
- 1.Sinha S, Uchibe K, Usami Y, Pacifici M, Iwamoto M. Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent. Bone. 2016/02/20 edn; 2016.Google Scholar
- 5.Grohs JG, Schmidt M, Wanivenhaus A. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop. 2007;78(1):95–8. doi: 10.1080/17453670610013484.CrossRefPubMedGoogle Scholar
- 9.Sun Y, Cai J, Li F, Liu S, Ruan H, Fan C. The efficacy of celecoxib in preventing heterotopic ossification recurrence after open arthrolysis for post-traumatic elbow stiffness in adults. J Shoulder Elbow Surg. 2015;24(11):1735–40. doi: 10.1016/j.jse.2015.07.006S1058-2746(15)00380-8.CrossRefPubMedGoogle Scholar
- 10.Schug SA, Joshi GP, Camu F, Pan S, Cheung R. Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data. Anesth Analg. 2009;108(1):299–307. doi: 10.1213/ane.0b013e31818ca3ac108/1/299.CrossRefPubMedGoogle Scholar
- 18.Xue D, Zheng Q, Li H, Qian S, Zhang B, Pan Z. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials. Int Orthop. 2011;35(1):3–8. doi: 10.1007/s00264-009-0886-y.CrossRefPubMedGoogle Scholar
- 19.Schmidt M, Lamberts M, Olsen AM, Fosboll E, Niessner A, Tamargo J, et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J Cardiovasc Pharmacother. 2016;2(2):108–18. doi: 10.1093/ehjcvp/pvv054pvv054.CrossRefPubMedGoogle Scholar
- 21.Letournel E. Acetabulum fractures: classification and management. Clin Orthop Relat Res. 1980;151:81–106.Google Scholar
- 24.Bek D, Beksac B, Della Valle AG, Sculco TP, Salvati EA. Aspirin decreases the prevalence and severity of heterotopic ossification after 1-stage bilateral total hip arthroplasty for osteoarthrosis. J Arthroplasty. 2009;24(2):226–32. doi: 10.1016/j.arth.2007.11.008S0883-5403(07)00647-X.CrossRefPubMedGoogle Scholar